Return to Trial Database

HCRN-BRE02-43

A Pilot Trial Incorporating ZD1839 (IRESSA®) into Adjuvant Therapy for Breast Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making: BRE02-43

Trial Locations

All sites in which the trial HCRN-BRE02-43 being conducted in.

No data was found